PBAC recommends subsidised RSV vaccine for pregnant women The committee has backed Abrysvo being added to the NIP, but GPs have warned additional supply must be guaranteed to ensure a successful rollout.
Aggressive responses likely crystalise vaccine uncertainty: Study Online misinformation has often been blamed for the spike in vaccine hesitancy, but is social media abuse just as damaging?
‘Alarming’: Flu vaccination rates fall over 12% It’s the lowest level recorded by the NCIRS in at least four years, as health authorities warn of an increase in influenza-associated deaths.
In Practice: AIR updates ahead of flu season The Australian Immunisation Register has made enhancements to COVID-19 and influenza vaccine information in preparation for the 2024 winter season.
Australian child vaccination rates continue to fall Many jurisdictions are close to the herd immunity threshold for highly infectious diseases like measles, with some areas especially vulnerable.
Modelling reveals number of lives saved by COVID vaccine rollout Research suggests the campaign saved nearly 18,000 over-50s in NSW alone between August 2021 and July 2022.
Flucelvax QUAD now available on NIP The boost comes as Queensland and WA announce the rollout of subsidised flu vaccination programs to curb already surging cases.
Kids flu cases predicted to spike if vaccine rates remain low GPs have been urged to promote the vaccine among patients with young children, with just 28% of kids receiving the lifesaving immunisation.
Real-world evidence demonstrates efficacy of HPV vaccine Zero cases of cervical cancer have been detected in Scotland among those who received the bivalent vaccine by age 12.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.